![](/img/cover-not-exists.png)
Pegylated-interferon plus ribavirin treatment does not alter the prevalence of resistance-associated substitutions to direct-acting antivirals in HCV genotype 1a patients
Chen, Zhi-wei, Pang, Xi-chen, Li, Zhao, Ren, Hong, Hu, PengVolume:
Volume 10
Language:
english
Journal:
Infection and Drug Resistance
DOI:
10.2147/IDR.S145362
Date:
August, 2017
File:
PDF, 406 KB
english, 2017